Physician profile
Albert J Chang
NPI 1104089267
$289,615.73
in general payments reported to CMS, 2019-2025
29 companies · $68K in 2025
The $68K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,272 · 2020: $22K · 2021: $15K · 2022: $16K · 2023: $94K · 2024: $69K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $96K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $67K · Travel and Lodging: $38K · Food and Beverage: $18K · Honoraria: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $95,618.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $67,171.25 |
| Travel and Lodging | $38,088.28 |
| Food and Beverage | $17,717.81 |
| Honoraria | $12,512.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $95,786.56 | 2019-2025 | Spaceoar Vue System - 10ml, Clinical Trial Product, Spaceoar System |
| Gt Medical Technologies, INC | $34,092.73 | 2019-2025 | Gammatile, Gammatile |
| Palette Life Sciences, INC. | $32,426.39 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $32,069.67 | 2023-2025 | Orgovyx, Myfembree |
| Bard Peripheral Vascular, INC. | $31,080.77 | 2023-2024 | Model 200 Theraseed Palladium-103 In Readylink |
| Bioprotect Medical, INC. | $27,523.44 | 2024-2025 | Bioprotect Balloon Implant System |
| Stryker Corporation | $11,402.94 | 2022-2025 | Airo, Everest Spinal System, N/A |
| Myovant Sciences INC. | $10,043.04 | 2021-2022 | |
| Elekta, INC. | $6,086.15 | 2019-2024 | Elekta Medical Linear Accelerator |
| Varian Medical Systems, INC. | $2,120.05 | 2019 | |
| Astellas Pharma Global Development | $1,458.00 | 2023 | Xtandi |
| Theragenics Corporation | $1,297.01 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $1,130.18 | 2021-2025 | Erleada, Rybrevant |
| Brainlab, INC. | $1,000.00 | 2019 | |
| Viewray Technologies INC | $800.00 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $380.27 | 2024-2025 | Barrigel |
| Becton, Dickinson and Company | $250.33 | 2023-2024 | |
| Argon Medical Devices, INC. | $139.86 | 2023 | Cleaner |
| Intuitive Surgical, INC. | $99.72 | 2023 | Da Vinci Surgical System |
| Karl Storz Endoscopy-America | $89.23 | 2023 | C-View |
| Isoray, INC | $85.74 | 2022 | |
| Tesaro, INC. | $61.03 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $60.57 | 2025 | |
| Siemens Medical Solutions USA, INC. | $38.55 | 2021 | |
| Janssen Biotech, INC. | $25.73 | 2025 | Tremfya |
| Neotract INC. | $24.97 | 2019 | |
| Portola Pharmaceuticals, LLC | $22.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $20.15 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.